Navigation Links
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
Date:3/31/2008

ns or labeling for Lotrel or regarding potential future revenues from Lotrel. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with Lotrel to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Lotrel will be submitted or approved for any additional indications or labeling. Nor can there be any guarantee that Lotrel will achieve any particular levels of revenue in the future. In particular, management's expectations regarding Lotrel could be affected by, among other things, the company's ability to obtain or maintain patent or other proprietary intellectual property protection, including for the Lotrel 5/40 mg and 10/40 mg capsules; unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; competition in general; government, industry and general public pricing pressures, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovasc
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
2. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
3. New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
4. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
5. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
6. Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
7. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
8. New Drug Combination is Able to Eradicate Breast Metastases in Mice
9. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
10. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
11. Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... NEW YORK und KISSING, Deutschland, ... ein Hersteller und Distributor eines computerunterstützten („robotischen") ... Nachum (Homi) Shamir , ein weltweit ... seines Leitungs- und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener ...
(Date:7/31/2014)... LAWRENCEVILLE, N.J. , July 31, 2014  Celsion ... the Company will host a conference call to discuss ... EDT on Thursday, August 7, 2014. To participate in ... North America ) or 1-785-830-1924 (International/Toll) and ask ... (Conference Code: 8283269) to register ten minutes before the ...
(Date:7/31/2014)... 31, 2014 Endo International plc (NASDAQ: ... 2014 revenues of $719 million, an increase of 1 ... million. Endo reported net income of $21 million in ... $35 million in the second quarter of 2013.  As ... income for the three months ended June 30, 2014 increased ...
Breaking Medicine Technology:invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3Celsion Corporation to Hold Second Quarter 2014 Financial Results 2Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32
... , June 2 GlaxoSmithKline (NYSE: ... a letter from the U.S. Food and Drug Administration ... Serevent® and Advair®.  The letter concludes discussions between GSK ... the safety profile of long-acting beta2-agonists in the treatment ...
... Apnex Medical, Inc., a pioneer in developing novel medical device treatments for ... Charles (Chas) S. McKhann as President and Chief Executive Officer, effective immediately. ... (Photo:   http://www.newscom.com/cgi-bin/prnh/20100602/CG13931 ) , ... "In this dynamic healthcare environment, successfully bringing novel ...
Cached Medicine Technology:GSK Announces Revised Product Labels for Serevent® and Advair® 2Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer 2Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer 3
(Date:7/31/2014)... July 31, 2014 Recently, Agebc.com, a popular ... has revealed its new selection of trendy mother of ... are offered at promotional prices now, up to 68% off. ... by adding the new range of mother of the bride ... the international clients. So far, our online shop has received ...
(Date:7/31/2014)... 31, 2014 Ethane Web Technologies, ... introduced a new service named ‘Java Development’. The ... Technologies has designed the service after doing a ... Java Development service being provided by other web ... confidence to promise outstanding Java Development service. ...
(Date:7/31/2014)... for those with periodontal disease related to type 2 diabetes, ... report appearing in the August 2014 issue of the ... most important blood cells involved in the human immune response, ... in type 2 diabetes-associated periodontal disease. These findings support ... cells may treat or prevent this complication. , "Our ...
(Date:7/31/2014)... July 31, 2014 Healthpointe Medical ... strives in maintaining the highest standards in health ... why Healthpointe is offering Occupational Medicine Services ... employees and patients. They also accept workers’ compensation ... Healthpointe’s Occupational Medicine services include, but are not ...
(Date:7/31/2014)... FL. (PRWEB) July 31, 2014 ... USARAD Holdings Inc. a leading US Joint Commission ... the most innovative and technologically advanced consumer storage ... The teleradiology leader is providing valued members the ... enhancing the extraordinary services already offered by SecondOpinions.com®. ...
Breaking Medicine News(10 mins):Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3
... empathy similar to those in people with frontal lobe damage, ... impairments in psychopaths are similar to those in people with ... study finds. , Callousness and a lack of remorse and ... exact cause of these characteristics has been the subject of ...
... , ... Windcrest Will Collect Donated Hearing Aids on May 18th during Hearing Aid Roundup , ... New Braunfels, TX (Vocus) April 30, 2010 -- ... up their used hearing aids and mosey on down to the Hearing Aid Roundup at Estes ...
... catching, throwing lead to sedentary lifestyle, study finds , ... of disadvantaged preschool children in the United States have ... throwing and catching, a new study finds. , This ... on physical activity and becoming obese teens and adults, ...
... Calif.) A UC Davis team of cardiovascular specialists ... to traditional open-chest surgery -- to repair aortas that are ... their findings at the American Association for Thoracic Surgery Aortic ... City. "We are always looking for ways to reduce ...
... child care, treatment decisions and political advocacy, study finds , ... have more than just their parents in their corner, with ... key role in the lives of kids with the developmental ... financially to the care of youngsters with autism. In fact, ...
... Aqua satellites are helping the National Oceanic and Atmospheric Administration ... oil spill with satellite images from time to time. NOAA ... fly-overs to assess oil spill extent. A semisubmersible drilling ... of the Mississippi Delta experienced a fire and explosion at ...
Cached Medicine News:Health News:Estes Audiology and SERTOMA Club Windcrest Celebrate Better Hearing and Speech Month with Hearing Aid Roundup 2Health News:Estes Audiology and SERTOMA Club Windcrest Celebrate Better Hearing and Speech Month with Hearing Aid Roundup 3Health News:Motor Skills Lag in Poor Preschoolers 2Health News:Research team documents benefits of endovascular stent repair for traumatic aortic injury 2Health News:Grandparents Play Vital Role for Autistic Children 2Health News:Grandparents Play Vital Role for Autistic Children 3Health News:NASA satellite imagery keeping eye on the Gulf oil spill 2
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. Depth: 500 to 600....
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. Depth: 500 to 700....
Designed to remove cell debris or tissue remnants from the retina....
... Medtronic presents the Streamline family of ... have taken the gold standard in temporary ... that make them easy to use and ... Streamline Temporary Pacing Leads are designed to ...
Medicine Products: